Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Hepatitis testing

¹New York Blood Center, New York 10021, USA.

Immunological Investigations

|January 1, 1995

Summary

This summary is machine-generated.

Recent advancements in hepatitis testing have significantly reduced hepatitis B and C transmission via blood products. Hepatitis A transmission remains rare, with overall post-transfusion hepatitis incidence now similar to that of non-transfused patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Salivary proteomic profile of young healthy subjects.

Frontiers in molecular biosciences·2023

Same author

Highly pathogenic avian influenza virus H5N6 (clade 2.3.4.4b) has a preferable host tropism for waterfowl reflected in its inefficient transmission to terrestrial poultry.

Virology·2021

Same author

Suspected collision trauma deaths in pied wagtails.

The Veterinary record·2020

Same author

Investigation into the Pathology of Idiopathic Systemic Amyloidosis in Four Captive Badgers (Meles meles).

Journal of comparative pathology·2020

Same author

Subclinical BCG-osis in a Captive Badger (Meles meles) with Lymphoma.

Journal of comparative pathology·2020

Same author

Corrigendum to "In vitro permeability of silver nanoparticles through porcine oromucosal membrane" [Colloids Surf. B Biointerfaces 132 (August) (2015) 10-16].

Colloids and surfaces. B, Biointerfaces·2019

Same journal

The Emerging Role of Tumor-Associated Neutrophils in Modulating Immune Checkpoint Inhibitor Response and Therapeutic Strategies.

Immunological investigations·2026

Same journal

Immune Reconstitution After Hematopoietic Stem Cell Transplantation: Cellular Dynamics, Clinical Determinants, and Emerging Therapeutic Strategies.

Immunological investigations·2026

Same journal

Riboflavin Modulates Complement Activation, Immune Cell Viability and Activation, and Neutrophil Microbicidal Functions <i>in Vitro</i>.

Immunological investigations·2026

Same journal

Pharmacological Modulation of Immunosenescence and Inflammaging: Senolytics, Senomorphics, and Emerging Therapies.

Immunological investigations·2026

Same journal

Nanoantibodies: A Review of Diagnostic and Therapeutic Applications in Respiratory Diseases.

Immunological investigations·2026

Same journal

TRIM31: A Novel Guardian Against Periodontal Inflammation via Modulation of NLRP3 Inflammasome and Macrophage Polarization.

Immunological investigations·2026

See all related articles

Area of Science:

Hepatology
Transfusion Medicine
Virology

Background:

Hepatitis transmission through blood products poses a significant public health risk.
Progress in diagnostic testing has been crucial in mitigating this risk.
Hepatitis A, B, and C are key concerns in transfusion-transmitted infections.

Purpose of the Study:

To review the current status of hepatitis transmission via blood products.
To highlight advancements in screening tests for Hepatitis A, B, and C.
To assess the impact of these advancements on post-transfusion hepatitis incidence.

Main Methods:

Literature review of recent studies on hepatitis transmission and testing.
Analysis of epidemiological data on post-transfusion hepatitis.

Related Experiment Videos

Evaluation of the efficacy of current and emerging hepatitis screening assays.

Main Results:

Hepatitis A transmission by blood products is rare, though noted with Factor VIII concentrates.
Hepatitis B transmission significantly reduced by HBsAg and HBcAb screening.
Hepatitis C transmission substantially reduced by second-generation anti-HCV antibody tests; new tests promise further risk reduction.
Current incidence of post-transfusion hepatitis is indistinguishable from hepatitis in non-transfused patients.

Conclusions:

Hepatitis screening tests have dramatically improved blood product safety.
The risk of transfusion-transmitted hepatitis B and C is now minimal.
Continued vigilance and adoption of new testing technologies are essential for maintaining blood safety.